{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:11:57Z","timestamp":1790255517167,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.mayocpiqo.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T01:01:39Z","timestamp":1604278899000},"page":"137-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-0353","authenticated-orcid":false,"given":"Imad M.","family":"Tleyjeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakariya","family":"Kashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oweida","family":"AlDosary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haytham","family":"Tlayjeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa A.","family":"Garbati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Tleyjeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-0484","authenticated-orcid":false,"given":"Mouaz H.","family":"Al-Mallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Rizwan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1522-3915","authenticated-orcid":false,"given":"Dana","family":"Gerberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-8609","authenticated-orcid":false,"given":"Aref A.","family":"Bin Abdulhak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-3333","authenticated-orcid":false,"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Kashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.10.005_bib1","doi-asserted-by":"crossref","first-page":"106028","DOI":"10.1016\/j.ijantimicag.2020.106028","article-title":"A\u00a0review on possible modes of actions of chloroquine\/hydroxychloroquine: repurposing against SAR-COV-2 (COVID 19) pandemic","volume":"56","author":"Tripathy","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.10.005_bib2","doi-asserted-by":"crossref","first-page":"e0212614","DOI":"10.1371\/journal.pone.0212614","article-title":"Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: role of reduced inflammation and endothelial dysfunction","volume":"14","author":"Miranda","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.10.005_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.mayocpiqo.2020.10.005_bib4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In\u00a0vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib5","author":"Weston"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.10.005_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.10.005_bib7","first-page":"185","article-title":"[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia.]","volume":"43","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.10.005_bib8","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.10.005_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650500514558","article-title":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia","volume":"44","author":"Chen","year":"2006","journal-title":"Clin Toxicol (Phila)"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2020.10.005_bib11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.echo.2005.01.012","article-title":"Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction","volume":"18","author":"Keating","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.10.005_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ehf2.12276","article-title":"Chloroquine-induced cardiomyopathy: a reversible cause of heart failure","volume":"5","author":"Yogasundaram","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2020.10.005_bib13","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cjca.2014.08.016","article-title":"Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment","volume":"30","author":"Yogasundaram","year":"2014","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2020.10.005_bib14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2020.05.014","article-title":"QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin","volume":"17","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2020.10.005_bib15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib16","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.mayocpiqo.2020.10.005_bib17","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib18","author":"Wells"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.10.005_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s12350-017-1081-y","article-title":"Incidence of atrioventricular block with vasodilator stress SPECT: a meta-analysis","volume":"26","author":"Andrikopoulou","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.10.005_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/bimj.201400119","article-title":"Measures of single arm outcome in meta-analyses of rare events in the presence of competing risks","volume":"57","author":"Andreano","year":"2015","journal-title":"Biom J"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2020.10.005_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/sim.3511","article-title":"Why add anything to nothing? The arcsine difference as a measure of treatment effect\u00a0in meta-analysis with zero cells","volume":"28","author":"R\u00fccker","year":"2009","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.10.005_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.10.005_bib23","first-page":"48","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib24","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.10.005_bib25","doi-asserted-by":"crossref","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib26","first-page":"ciaa394","article-title":"Towards optimization of hydroxychloroquine dosing in intensive care unit COVID-19 patients","author":"Perinel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib27","doi-asserted-by":"crossref","first-page":"m1844","DOI":"10.1136\/bmj.m1844","article-title":"Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data","volume":"369","author":"Mah\u00e9vas","year":"2020","journal-title":"BMJ"},{"issue":"7-8","key":"10.1016\/j.mayocpiqo.2020.10.005_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12471-020-01429-7","article-title":"Chloroquine-induced QTc prolongation in COVID-19 patients","volume":"28","author":"van den Broek","year":"2020","journal-title":"Neth Heart J"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2020.10.005_bib29","doi-asserted-by":"crossref","first-page":"e008662","DOI":"10.1161\/CIRCEP.120.008662","article-title":"The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection","volume":"13","author":"Saleh","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2020.10.005_bib30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2020.1787","article-title":"Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit","volume":"5","author":"Bessi\u00e8re","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2020.10.005_bib31","doi-asserted-by":"crossref","first-page":"e0237693","DOI":"10.1371\/journal.pone.0237693","article-title":"Hydroxychloroquine and tocilizumab therapy in COVID-19 patients\u2014an observational study","volume":"15","author":"Ip","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2020.10.005_bib32","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.hrthm.2020.04.047","article-title":"Enhanced ECG monitoring\u00a0of COVID-19 patients","volume":"17","author":"Jain","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib33","doi-asserted-by":"crossref","first-page":"101738","DOI":"10.1016\/j.tmaid.2020.101738","article-title":"Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France","volume":"35","author":"Million","year":"2020","journal-title":"Travel Med Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.10.005_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"Med Mal Infect"},{"issue":"24","key":"10.1016\/j.mayocpiqo.2020.10.005_bib35","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2020.10.005_bib36","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/ajt.15929","article-title":"COVID-19 in solid organ transplant recipients: a single-center case series from Spain","volume":"20","author":"Fern\u00e1ndez-Ruiz","year":"2020","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2020.10.005_bib37","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2020.10.005_bib38","doi-asserted-by":"crossref","first-page":"e017144","DOI":"10.1161\/JAHA.120.017144","article-title":"Experience with hydroxychloroquine and azithromycin in the COVID-19 pandemic: implications for QT interval monitoring","volume":"9","author":"Ramireddy","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2020.05.036","article-title":"Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin","author":"Cipriani","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mayocpiqo.2020.10.005_bib40","first-page":"280","article-title":"Inpatient use of ambulatory telemetry monitors for COVID-19 patients treated with hydroxychloroquine and\/or azithromycin","volume":"316","author":"Chang","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.10.005_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mayocp.2013.01.013","article-title":"Institution-wide QT alert system identifies patients\u00a0with a high risk of mortality","volume":"88","author":"Haugaa","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.10.005_bib42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/CCM.0b013e318232db4a","article-title":"High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study","volume":"40","author":"Pickham","year":"2012","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.10.005_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/107424840200700202","article-title":"Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride","volume":"7","author":"Barbey","year":"2002","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.10.005_bib44","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/pr.110.003723","article-title":"Drug-induced long QT syndrome","volume":"62","author":"Kannankeril","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.10.005_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1586\/17512433.2016.1100073","article-title":"An update on risk factors for drug-induced arrhythmias","volume":"9","author":"Vlachos","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2020.10.005_bib46","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"issue":"20","key":"10.1016\/j.mayocpiqo.2020.10.005_bib47","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.10.005_bib48","doi-asserted-by":"crossref","first-page":"e003560","DOI":"10.1161\/CIRCEP.115.003560","article-title":"Azithromycin causes a novel proarrhythmic syndrome","volume":"10","author":"Yang","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454820302058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454820302058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T18:36:16Z","timestamp":1726684576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454820302058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2542454820302058"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.10.005","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.16.20132878","asserted-by":"object"}]},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}